Apitoria Pharma Private Limited, a active private limited company, was established on 20 December 2017 in Hyderabad, Telangana, India. Engaging in specialty chemicals within the manufacturing sector, it holds CIN: U24298TG2017PTC121342. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹100.00 Cr and a paid-up capital of ₹99.00 Cr.
Formerly known as Auro Pharma India Private Limited. It upholds a compliant status. Employing 4,732 professional, Its leadership includes Nityananda Reddy Kambam (Director), Mylandlahalli Rammohan Ashwini (Director), Satakarni Makkapati (Director). Past directors included Venkat Nageswar Chalasani, Nityananda Reddy Kambam, Sapna. It holds ₹1,500.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Galaxy, Floors 22-24, Plot No. 1, Survey No. 83/1 Hyderabad Knowledge City, Raidurg Panmak, Tha, Hyderabad, Telangana, 500032.
U24298TG2017PTC121342
121342
20 December 2017
₹100.00 Cr
₹99.00 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Apitoria Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nityananda Reddy Kambam | Director | 09 Feb 2023 | Current |
| Mylandlahalli Rammohan Ashwini | Director | 29 Mar 2024 | Current |
| Satakarni Makkapati | Director | 23 May 2023 | Current |
| Santhanam Subramanian | Director | 09 Feb 2023 | Current |
| Santanu Mukherjee | Additional Director | 31 Jul 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 20 Aug 2023 | Past |
| Pramod Abcsdd | Director | 10 Jun 2019 | Past |
| Pramod Abcsdd | Additional Director | 26 Aug 2019 | Past |
| Pramod Abcsdd | Additional Director | 11 Aug 2024 | Past |
| Pramod Abcsdd | Additional Director | 20 Aug 2023 | Past |
| Pramod Abcsdd | Additional Director | 20 Aug 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Apitoria Pharma Private Limited, for the financial year ended 2025, experienced significant growth in revenue, with a 19.66% increase. The company also saw a substantial improvement in profitability, with a 32.84% increase in profit. The company's net worth Soared by an impressive increase of 167.15%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Apitoria Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹15,000,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Oct 2023 | State Bank Of India | ₹1,500.00 Cr | Open |
Explore comprehensive loan charge details -
Apitoria Pharma has a workforce of 4732 employees as of Nov 04, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Apitoria Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Apitoria Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Apitoria Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
Progress on Santanu Mukherjee was appointed as a Additional Director was appointed as a Additional Director on 31 Jul 2025 & has been associated with this company since 4 months 2 days . was documented.
A charge with State Bank Of India of Rs. 1,500.00 Cr registered on 30 Oct 2023 with Charge ID 100812350 was modified on 17 Apr 2025. was recorded as a recent event.
Progress on Apitoria Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was documented.
Progress on Srinivas Bodige was appointed as a Company Secretary was appointed as a Company Secretary on 15 Nov 2024 & has been associated with this company since 1 year 15 days . was documented.
Progress on Brundaban Dash was appointed as a Cfo was appointed as a Cfo on 19 Apr 2024 & has been associated with this company since 1 year 7 months . was documented.
The CIN of Apitoria Pharma Private Limited is U24298TG2017PTC121342.
Apitoria Pharma Private Limited is headquartered at Galaxy, Floors 22-24, Plot No. 1, Survey No. 83/1 Hyderabad Knowledge City, Raidurg Panmak, Tha, Hyderabad, Telangana, 500032.
Apitoria Pharma Private Limited was incorporated on 20 December 2017.
The current directors of Apitoria Pharma Private Limited are
The primary industry of Apitoria Pharma Private Limited is Manufacturing.
Apitoria Pharma Private Limited is unlisted.
The authorized capital of Apitoria Pharma Private Limited is ₹100.00 Cr, and the paid-up capital is ₹99.00 Cr.
The compliance status of Apitoria Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX